- Report
- October 2024
- 186 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Clinical Trials
- November 2024
- 80 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- December 2024
- 65 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- October 2021
- 100 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- August 2020
- 112 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- December 2023
- 62 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- February 2024
- 25 Pages
Global
€15608EUR$17,150USD£13,381GBP
- Report
- May 2023
- 112 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP

Allopurinol is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and lupus. It works by reducing the production of uric acid, which can cause inflammation and pain in the joints. Allopurinol is also used to prevent gout attacks and kidney stones. It is available in both oral and intravenous forms.
Allopurinol is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has few side effects. It is also relatively inexpensive compared to other drugs used to treat these conditions.
The Allopurinol market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more